CTLA4 and hypophysitis: Pituitary autoantibodies targeting thyrotrophs, corticotrophs, and gonadotrophs have been detected in patients treated with anti-CTLA-4 antibodies (e.g., ipilimumab) who subsequently developed hypophysitis [11].